Rafferty Asset Management
TECX

Rafferty Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Rafferty Asset Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,079
Closed -$969K – 1318
2021
Q2 		$969K Buy
9,079
+833
+10% +$98.7K 0.01% 924
2021
Q1 		$1.26M Buy
8,246
+7,360
+831% +$1.2M 0.01% 720
2020
Q4 		$148K Sell
886
-1,366
-61% -$243K ﹤0.01% 1000
2020
Q3 		$352K Buy
+2,252
New +$454K ﹤0.01% 767
2020
Q1 		– Sell
-1,066
Closed -$258K – 823
2019
Q4 		$258K Sell
1,066
-1,424
-57% -$275K ﹤0.01% 812
2019
Q3 		$422K Buy
+2,490
New +$564K 0.01% 696

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Rafferty Asset Management's TECX Position: Q3 2021 in Review

Rafferty Asset Management sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 9,079 shares — an estimated $969K sold.

Rafferty Asset Management first reported a position in TECX in Q3 2019 and held it in 6 quarters. The position peaked at $1.26M in Q1 2021. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Rafferty Asset Management reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 9,079 Tectonic Therapeutic shares in Q3 2021, an estimated $969K.
  • Rafferty Asset Management first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 6 quarters.
  • Rafferty Asset Management's Tectonic Therapeutic position peaked at $1.26M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.